Do you have a dispute with a business?
Make it public
REDX PHARMA PLC
BLOCK 33 MERESIDE, ALDERLEY PARK, MACCLESFIELD, SK10 4TGCompany Number: 07368089
Incorporation date: 07-Sep-2010
Status: Active
Entity type: Public Limited Company
SIC codes:
72110 Research and experimental development on biotechnology
SUMMARY
This company is 13.6 years old and is currently active. It is controlled by multiple entities. The company has positive equity (net assets) of GBP 2.7 thousand which has increased from GBP 1.5 thousand in the previous year. The latest reported revenue figure is GBP 5.7 thousand which is up 80% on previous year's figure of GBP 3.1 thousand. The company has 7 active officers (directors or partners) who are or were officers of 80 other companies, 34 (42.5%) of which have since been dissolved or are proposed for strike off. The company has no public disputes filed on the Business Disputes Register. There are no court cases involving the company that we are aware of.FINANCIALS (BETA)
Next accounts due: 31-Mar-2024Accounts Filed: GROUP (30-Sep-2022)
P&L Financials:
Year end | Currency | Revenue | Operating profit | Interest Received | Interest Paid | Tax | Net Profit GBP |
---|---|---|---|---|---|---|---|
30-Sep-2020 | GBP | 5,685 | 7 | 974 | -45 | ||
30-Sep-2019 | GBP | 3,131 | 12 | 102 | 2,017 | ||
30-Sep-2018 | GBP | 129 | -10,169 | 24 | 1 | 1,301 |
Balance Sheet Financials:
Year end | Currency | Cash | Current Assets | Current Liabilities | Debt | Share Capital | Premium Reserve | Retained Earnings | Net Assets |
---|---|---|---|---|---|---|---|---|---|
30-Sep-2020 | GBP | 27,513 | 29,468 | 10,934 | 1,952 | 8 | 2,687 | ||
30-Sep-2019 | GBP | 3,704 | 5,807 | 4,867 | 468 | 1,265 | 33,263 | 1,491 | |
30-Sep-2018 | GBP | 6,471 | 9,705 | 3,950 | 1,265 | 33,263 | 5,764 |
VALUATION EVENTS (BETA)
Year end | Currency | % Equity | Sum raised | Pre-Money Valuation* | Post-Money Valuation* | Enterprise Value** |
---|---|---|---|---|---|---|
30-Sep-2020 | GBP | 35.19% | -32,568 | -59,969 | -92,537 | -91,627 |
** Estimated based on average Cash and Debt levels during period
DISPUTES
No disputes filed on www.disputesregister.orgCOMPANY SECRETARY
Status | Name | Appointed on | Resigned on | Occupation | Nationality | All apointments (active/resigned) |
---|---|---|---|---|---|---|
Active | Claire Penelope SOLK | 01 Sep 2022 | 28 Mar 2024 | 1 - 0 | ||
Resigned | Andrew William BOOTH | 16 May 2017 | 01 Sep 2022 | 0 - 1 | ||
Resigned | Simon William THORN | 20 Sep 2010 | 16 May 2017 | British | 0 - 1 |
DIRECTORS
Status | Name | Appointed on | Resigned on | Occupation | Nationality | All appointments (active/resigned) |
Dissolved companies (rate) |
---|---|---|---|---|---|---|---|
Active | Joseph, Dr ANDERSON | 06 Sep 2023 | Director | British | 1 - 0 | 0 (0.0%) | |
Active | Robert Andrew Donald SCOTT | 27 Jan 2022 | Physician | American | 1 - 0 | 0 (0.0%) | |
Active | Jane Veronica, Dr GRIFFITHS | 01 Dec 2021 | Company Director | British | 1 - 0 | 0 (0.0%) | |
Active | Natalie BERNER | 18 May 2021 | Co Director | American | 1 - 0 | 0 (0.0%) | |
Resigned | Thomas Henry BURT | 04 Aug 2020 | 01 Sep 2023 | Finance Professional | British | 0 - 3 | 0 (0.0%) |
Resigned | Sarah Lucinda GORDON WILD | 01 Jul 2020 | 30 Sep 2023 | Company Director | British | 3 - 4 | 0 (0.0%) |
Resigned | James Robert, Dr MEAD | 01 Feb 2019 | 02 Mar 2021 | Finance Director | British | 2 - 2 | 1 (25.0%) |
Active | Lisa Mary Whewell ANSON | 01 Jun 2018 | Pharmaceuticals Executive | British | 3 - 2 | 1 (20.0%) | |
Resigned | Dominic Nicholas JACKSON | 03 Nov 2017 | 31 Jan 2019 | Private Equity | British | 2 - 8 | 3 (30.0%) |
Active | Peter Eric PRESLAND | 03 Nov 2017 | Chartered Accountant | British | 11 - 73 | 35 (41.7%) | |
Resigned | Iain Gladstone ROSS | 01 May 2017 | 31 May 2021 | Company Director | British | 0 - 8 | 1 (12.5%) |
Resigned | David Muir LAWRENCE | 06 May 2016 | 14 Aug 2017 | Director | British | 2 - 12 | 3 (21.4%) |
Active | Bernhard Jurgen KIRSCHBAUM | 01 Jan 2016 | Director | German | 1 - 0 | 0 (0.0%) | |
Resigned | Philip John TOTTEY | 25 Mar 2015 | 30 Sep 2016 | Company Director | British | 0 - 13 | 4 (30.8%) |
Resigned | Frank Murdoch ARMSTRONG | 01 Sep 2014 | 20 Apr 2017 | Chairman | British | 6 - 7 | 1 (7.7%) |
Resigned | Dennis William Patrick HALLAHANE | 15 Nov 2011 | 21 May 2014 | Director | British | 2 - 19 | 7 (33.3%) |
Resigned | Peter MCPARTLAND | 18 Oct 2010 | 20 Apr 2017 | Director | British | 5 - 23 | 11 (39.3%) |
Resigned | Douglas Colin Walter STELLMAN | 20 Sep 2010 | 20 Apr 2011 | Investment Manager | British | 2 - 7 | 3 (33.3%) |
Resigned | Neil David MURRAY | 20 Sep 2010 | 03 Nov 2017 | Company Director | British | 3 - 8 | 3 (27.3%) |
Resigned | Derek LINDSAY | 20 Sep 2010 | 06 May 2016 | Director | British | 0 - 8 | 2 (25.0%) |
Resigned | Peter, Dr JACKSON | 20 Sep 2010 | 31 Mar 2017 | Director | British | 3 - 13 | 5 (31.3%) |
Resigned | Philip Leon, Dr GOULD | 20 Sep 2010 | 31 May 2014 | Executive | British | 1 - 14 | 8 (53.3%) |
Resigned | Norman MOLYNEUX | 07 Sep 2010 | 03 Nov 2017 | None | British | 3 - 89 | 60 (65.2%) |
Average tenure of active directors: 4.1 years
Average tenure of resigned directors: 3.7 years
Average active director Dissolution Rate: 8.8%
DIRECTOR APPOINTMENTS IN OTHER COMPANIES
SHAREHOLDERS (BETA)
Shareholder name | Share class | Shares at confirmation date | ||||
---|---|---|---|---|---|---|
2017-09-07 | 2016-09-07 | 2014-09-07 | 2013-09-07 | 2012-09-07 | ||
PERSHING NOMINEES LIMITED THE ROYAL LIVER PIER HEAD | ORDINARY | 13,643,107 31.4% | 12,554,345 31.0% | 0 0% | 0 0% | 0 0% |
HSBC GLOBAL CUSTODY NOMINEE (UK) LIMITED 8 CANADA SQUARE | ORDINARY | 12,286,220 28.3% | 0 0% | 0 0% | 0 0% | 0 0% |
SHARE NOMINEES LIMITED OXFORD HOUSE OXFORD ROAD | ORDINARY | 9,977,009 23.0% | 4,778,996 11.8% | 0 0% | 0 0% | 0 0% |
CHASE (GA GROUP) NOMINEES LIMITED 1 CHASESIDE | ORDINARY | 7,530,955 17.3% | 0 0% | 0 0% | 0 0% | 0 0% |
HSBC GLOBAL CUSTODY NOMINEE (UK) LIMITED 8 CANADA SQUARE LONDON UNITED KINGDOM E14 5HQ | ORDINARY | 0 0% | 9,214,000 22.8% | 0 0% | 0 0% | 0 0% |
CHASE (GA GROUP) NOMINEES LIMITED 1 CHASESIDE BOURNEMOUTH UNITED KINGDOM BH1 9XA | ORDINARY | 0 0% | 7,166,980 17.7% | 0 0% | 0 0% | 0 0% |
PERSHING NOMINEES LIMITED THE ROYAL LIVER PIER HEAD | ORDINARY | 0 0% | 6,782,489 16.7% | 0 0% | 0 0% | 0 0% |
JONATHAN MOULTON | ORDINARY | 0 0% | 0 0% | 133,318 24.0% | 0 0% | 100,787 27.0% |
ALLIANCE FUND MANAGERS NOMINEES LIMITED | ORDINARY B | 0 0% | 0 0% | 59,800 10.8% | 0 0% | 59,800 16.0% |
NW VCF HF LLP | ORDINARY | 0 0% | 0 0% | 46,757 8.42% | 0 0% | 0 0% |
PETER JACKSON | ORDINARY | 0 0% | 0 0% | 37,500 6.75% | 0 0% | 0 0% |
DEREK LINDSAY | ORDINARY | 0 0% | 0 0% | 26,699 4.81% | 0 0% | 26,366 7.07% |
DENNIS HALLAHANE | ORDINARY | 0 0% | 0 0% | 21,662 3.90% | 0 0% | 20,328 5.45% |
WOODSIDE CORPORATE SERVICES LIMITED | ORDINARY | 0 0% | 0 0% | 19,780 3.56% | 0 0% | 0 0% |
ALLIANCE FUND MANAGERS NOMINEES LIMITED | ORDINARY | 0 0% | 0 0% | 16,178 2.91% | 0 0% | 15,500 4.16% |
ACCELERIS LIMITED | ORDINARY | 0 0% | 0 0% | 15,700 2.83% | 0 0% | 15,700 4.21% |
ACCELERIS (NOMINEES) LIMITED | ORDINARY | 0 0% | 0 0% | 11,892 2.14% | 0 0% | 0 0% |
ANTHONY HITCHEN | ORDINARY | 0 0% | 0 0% | 11,266 2.03% | 0 0% | 10,389 2.79% |
AMANDA COWBURN | ORDINARY | 0 0% | 0 0% | 8,300 1.49% | 0 0% | 0 0% |
MARK GETLIFFE | ORDINARY | 0 0% | 0 0% | 8,086 1.46% | 0 0% | 5,639 1.51% |
JEREMY THOMAS | ORDINARY | 0 0% | 0 0% | 7,867 1.42% | 0 0% | 0 0% |
GEOFF BROOMHEAD | ORDINARY | 0 0% | 0 0% | 7,333 1.32% | 0 0% | 0 0% |
VOLAW TRUSTEE LIMITED AS TRUSTEE OF THE VALENTINE TRUST | ORDINARY | 0 0% | 0 0% | 5,735 1.03% | 0 0% | 0 0% |
PETER JACKSON PILGRIM SIPP | ORDINARY | 0 0% | 0 0% | 5,294 0.953% | 0 0% | 46,757 12.5% |
OSCAR TYMON | ORDINARY | 0 0% | 0 0% | 4,826 0.869% | 0 0% | 4,418 1.19% |
ROBERT CURRY | ORDINARY | 0 0% | 0 0% | 4,488 0.808% | 0 0% | 3,595 0.964% |
ALAN GRANT | ORDINARY | 0 0% | 0 0% | 3,836 0.691% | 0 0% | 3,675 0.986% |
DAVID ATHERTON | ORDINARY | 0 0% | 0 0% | 3,806 0.685% | 0 0% | 2,688 0.721% |
PAULENE HALLAHANE | ORDINARY | 0 0% | 0 0% | 3,634 0.655% | 0 0% | 2,138 0.574% |
GRAHAM EDWARDS | ORDINARY | 0 0% | 0 0% | 3,332 0.600% | 0 0% | 0 0% |
NORMAN MOLYNEUX | ORDINARY | 0 0% | 0 0% | 3,158 0.569% | 0 0% | 2,510 0.673% |
PHILIP GOULD | C ORDINARY | 0 0% | 0 0% | 2,931 0.528% | 0 0% | 0 0% |
SARAH HOOKER | ORDINARY | 0 0% | 0 0% | 2,721 0.490% | 0 0% | 2,607 0.699% |
DUNCAN BROWN | ORDINARY | 0 0% | 0 0% | 2,711 0.488% | 0 0% | 2,597 0.697% |
CHRIS HOPKINSON | ORDINARY | 0 0% | 0 0% | 2,700 0.486% | 0 0% | 0 0% |
SUSAN TYMON | ORDINARY | 0 0% | 0 0% | 2,676 0.482% | 0 0% | 2,564 0.688% |
JAMES MARTIN | ORDINARY | 0 0% | 0 0% | 2,667 0.480% | 0 0% | 0 0% |
HAMISH MCPHERSON | ORDINARY | 0 0% | 0 0% | 2,667 0.480% | 0 0% | 0 0% |
RICHARD PARRY | ORDINARY | 0 0% | 0 0% | 2,667 0.480% | 0 0% | 0 0% |
THOMAS BLOXHAM | ORDINARY | 0 0% | 0 0% | 2,666 0.480% | 0 0% | 0 0% |
CLIVE RICHARDS | ORDINARY | 0 0% | 0 0% | 2,666 0.480% | 0 0% | 0 0% |
NEIL MURRAY | ORDINARY | 0 0% | 0 0% | 2,664 0.480% | 0 0% | 0 0% |
GURDON WATTLES | ORDINARY | 0 0% | 0 0% | 2,652 0.478% | 0 0% | 2,050 0.550% |
STEPHEN FALL | ORDINARY | 0 0% | 0 0% | 2,500 0.450% | 0 0% | 0 0% |
WHITE ROSE NOMINEES LTD | ORDINARY | 0 0% | 0 0% | 2,426 0.437% | 0 0% | 4,296 1.15% |
VASSAR INVESTMENTS | ORDINARY | 0 0% | 0 0% | 2,411 0.434% | 0 0% | 0 0% |
KATHRYN GRANT | ORDINARY | 0 0% | 0 0% | 2,385 0.430% | 0 0% | 1,794 0.481% |
ROSEMARY FALL | ORDINARY | 0 0% | 0 0% | 2,065 0.372% | 0 0% | 2,000 0.536% |
ANDROULLA DONALDSON | ORDINARY | 0 0% | 0 0% | 2,003 0.361% | 0 0% | 1,903 0.510% |
PAUL DEWINTER | ORDINARY | 0 0% | 0 0% | 2,000 0.360% | 0 0% | 0 0% |
TIM MURPHY | ORDINARY | 0 0% | 0 0% | 1,893 0.341% | 0 0% | 0 0% |
STEVEN CHARNOCK | ORDINARY | 0 0% | 0 0% | 1,893 0.341% | 0 0% | 0 0% |
IAN CURRIE | ORDINARY | 0 0% | 0 0% | 1,893 0.341% | 0 0% | 0 0% |
JADARA PHARMA LTD | ORDINARY | 0 0% | 0 0% | 1,880 0.339% | 0 0% | 1,880 0.504% |
BRIDGET HALLAHANE | ORDINARY | 0 0% | 0 0% | 1,651 0.297% | 0 0% | 1,582 0.424% |
ANDREW TAIT | ORDINARY | 0 0% | 0 0% | 1,633 0.294% | 0 0% | 1,074 0.288% |
MICHAEL LLOYD | ORDINARY | 0 0% | 0 0% | 1,500 0.270% | 0 0% | 1,000 0.268% |
DIANA SCOTT | ORDINARY | 0 0% | 0 0% | 1,500 0.270% | 0 0% | 1,500 0.402% |
GARY MIDDLEBROOK | ORDINARY | 0 0% | 0 0% | 1,334 0.240% | 0 0% | 0 0% |
CHARLES ORSBORN | ORDINARY | 0 0% | 0 0% | 1,269 0.229% | 0 0% | 0 0% |
GEOFFREY MASON | ORDINARY | 0 0% | 0 0% | 1,269 0.229% | 0 0% | 0 0% |
DAVID YOUNGMAN | ORDINARY | 0 0% | 0 0% | 1,086 0.196% | 0 0% | 638 0.171% |
BARRIE THORPE | ORDINARY | 0 0% | 0 0% | 1,084 0.195% | 0 0% | 1,039 0.279% |
PETER MCPARTLAND | ORDINARY | 0 0% | 0 0% | 1,039 0.187% | 0 0% | 1,039 0.279% |
STAR SICAV | ORDINARY | 0 0% | 0 0% | 933 0.168% | 0 0% | 0 0% |
IAN BATTERSBY | ORDINARY | 0 0% | 0 0% | 827 0.149% | 0 0% | 0 0% |
DANIEL COWBURN | ORDINARY | 0 0% | 0 0% | 800 0.144% | 0 0% | 0 0% |
ALEXANDRA COWBURN | ORDINARY | 0 0% | 0 0% | 800 0.144% | 0 0% | 0 0% |
JAMES COWBURN | ORDINARY | 0 0% | 0 0% | 800 0.144% | 0 0% | 0 0% |
GEOFFREY WAINWRIGHT | ORDINARY | 0 0% | 0 0% | 784 0.141% | 0 0% | 0 0% |
FITEL NOMINEES LIMITED | ORDINARY | 0 0% | 0 0% | 779 0.140% | 0 0% | 256 0.069% |
RICHARD MANLEY | ORDINARY | 0 0% | 0 0% | 720 0.130% | 0 0% | 0 0% |
DAVID JARRETT | ORDINARY | 0 0% | 0 0% | 700 0.126% | 0 0% | 0 0% |
ROY DAVIES | ORDINARY | 0 0% | 0 0% | 667 0.120% | 0 0% | 0 0% |
DUNCAN COWBURN | ORDINARY | 0 0% | 0 0% | 659 0.119% | 0 0% | 0 0% |
GEOFFREY WAINWRIGHT | ORDINARY | 0 0% | 0 0% | 536 0.097% | 0 0% | 0 0% |
RBYS ROBERTS | ORDINARY | 0 0% | 0 0% | 536 0.097% | 0 0% | 0 0% |
IAN HEMINGWAY | ORDINARY | 0 0% | 0 0% | 534 0.096% | 0 0% | 0 0% |
SIMON THOMAS | ORDINARY | 0 0% | 0 0% | 440 0.079% | 0 0% | 0 0% |
SIMON FINE | ORDINARY | 0 0% | 0 0% | 400 0.072% | 0 0% | 0 0% |
MALACHY MCENTYRE | ORDINARY | 0 0% | 0 0% | 400 0.072% | 0 0% | 0 0% |
PHILLIP GOULD | ORDINARY | 0 0% | 0 0% | 387 0.070% | 0 0% | 292 0.078% |
SUSAN WRIGHT | ORDINARY | 0 0% | 0 0% | 333 0.060% | 0 0% | 0 0% |
CHRIS BROOMHEAD | ORDINARY | 0 0% | 0 0% | 333 0.060% | 0 0% | 0 0% |
CORINTHIAN FUND | ORDINARY | 0 0% | 0 0% | 333 0.060% | 0 0% | 0 0% |
MARK CRAIGHEAD | ORDINARY | 0 0% | 0 0% | 324 0.058% | 0 0% | 310 0.083% |
STEPHEN HINDLEY | ORDINARY | 0 0% | 0 0% | 300 0.054% | 0 0% | 300 0.080% |
BASIL RICHARD I?'ANSON | ORDINARY | 0 0% | 0 0% | 267 0.048% | 0 0% | 0 0% |
RONNIE PALIN | ORDINARY | 0 0% | 0 0% | 267 0.048% | 0 0% | 256 0.069% |
ELLIOT SHAW | ORDINARY | 0 0% | 0 0% | 267 0.048% | 0 0% | 0 0% |
GILLIAN T'ANSON | ORDINARY | 0 0% | 0 0% | 267 0.048% | 0 0% | 0 0% |
THOMAS I?'ANSON | ORDINARY | 0 0% | 0 0% | 250 0.045% | 0 0% | 0 0% |
SIMON THORN | ORDINARY | 0 0% | 0 0% | 234 0.042% | 0 0% | 126 0.034% |
DANIEL FALLOWS | ORDINARY | 0 0% | 0 0% | 196 0.035% | 0 0% | 0 0% |
ANDREW CURRIE | ORDINARY | 0 0% | 0 0% | 187 0.034% | 0 0% | 0 0% |
THOMAS BATTERSBY | ORDINARY | 0 0% | 0 0% | 133 0.024% | 0 0% | 0 0% |
MARK HOPTON | ORDINARY | 0 0% | 0 0% | 100 0.018% | 0 0% | 0 0% |
RULEGALE NOMINEES LIMITED | ORDINARY | 0 0% | 0 0% | 92 0.017% | 0 0% | 667 0.179% |
ALAN FITZSIMMONS | ORDINARY | 0 0% | 0 0% | 80 0.014% | 0 0% | 0 0% |
IAIN DYMOCK | ORDINARY | 0 0% | 0 0% | 80 0.014% | 0 0% | 0 0% |
RICHARD ARTHUR | ORDINARY | 0 0% | 0 0% | 67 0.012% | 0 0% | 0 0% |
ROMAN TESLYA | ORDINARY | 0 0% | 0 0% | 27 0.005% | 0 0% | 0 0% |
JOANNE GANI | ORDINARY | 0 0% | 0 0% | 27 0.005% | 0 0% | 0 0% |
ALEXANDER DYMOCK | ORDINARY | 0 0% | 0 0% | 13 0.002% | 0 0% | 0 0% |
MARK MCELNEY | ORDINARY | 0 0% | 0 0% | 5 0.001% | 0 0% | 0 0% |
unknown | ORDINARY | 0 0% | 0 0% | 0 0% | 11,892 59.3% | 0 0% |
unknown | ORDINARY | 0 0% | 0 0% | 0 0% | 2,711 13.5% | 0 0% |
unknown | ORDINARY | 0 0% | 0 0% | 0 0% | 2,500 12.5% | 0 0% |
unknown | ORDINARY | 0 0% | 0 0% | 0 0% | 1,880 9.38% | 0 0% |
unknown | ORDINARY | 0 0% | 0 0% | 0 0% | 536 2.67% | 0 0% |
unknown | ORDINARY | 0 0% | 0 0% | 0 0% | 534 2.66% | 0 0% |
JEREMY .THOMAS | ORDINARY | 0 0% | 0 0% | 0 0% | 0 0% | 7,233 1.94% |
PETER JACKSON PILGRIM SIPP | ORDINARY | 0 0% | 0 0% | 0 0% | 0 0% | 5,072 1.36% |
PETER JACKSON PILGRIM SIPP | ORDINARY 37500 ORDINAR | 0 0% | 0 0% | 0 0% | 0 0% | 5,072 1.36% |
NEIL MURRAY | ORDLNARY | 0 0% | 0 0% | 0 0% | 0 0% | 2,331 0.625% |
ANDREW DAVIES | ORDINARY | 0 0% | 0 0% | 0 0% | 0 0% | 512 0.137% |
THE CONTINENTAL TRUST COMPANY LIMITED | ORDINARY | 0 0% | 0 0% | 0 0% | 0 0% | 494 0.133% |
RHYS ROBERTS | ORDINARY | 0 0% | 0 0% | 0 0% | 0 0% | 13 0.003% |
SHAREHOLDINGS (BETA)
no shareholding data
CONTROLLED COMPANIES / CONTROLLING ENTITIES
Controlling entities above
REDX PHARMA PLC
Controlled companies below
LATE PAYMENTS REPORT
This company has not filed any late payment reports possibly because it is not considered \'Large\'.
COURT CASES
No Court Cases found
PATENTS
Title | Date filed | Status | Publication number |
---|---|---|---|
Antibacterial compounds | 2016-09-16 | Terminated | GB2547740 |
Compounds | 2015-06-16 | Terminated | GB2548542 |
Compounds | 2014-07-16 | Terminated | GB2528298 |
Antiviral compounds | 2014-06-09 | Terminated | GB2532178 |
Compounds | 2013-10-18 | Terminated | GB2519344 |
Compounds | 2013-09-09 | Terminated | GB2517988 |
Compounds | 2013-07-18 | Terminated | GB2516303 |
Compounds | 2013-07-03 | Terminated | GB2515785 |
Antiviral drug derivatives | 2013-06-26 | Terminated | GB2516818 |
Derivatives of oseltamivir | 2012-12-19 | Terminated | GB2498080 |
Oxime and hydrazone derivatives of fluoroquinolone antibacterial drugs | 2012-11-16 | Terminated | GB2496972 |
COMPETITORS
(Based on Sic code:
72110 Research and experimental development on biotechnology)
Company | Registered Address | Company Number | YE Date | Revenue GBP | Net Profit GBP | Other SIC codes |
---|---|---|---|---|---|---|
ILLUMINA CAMBRIDGE LIMITED | 19 GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, CAMBRIDGESHIRE, ENGLAND, CB21 6DF | 03625145 | 2017-12-31 | 2,114,848,000 | 422,140,000 | |
IQVIA LTD. | 3 FORBURY PLACE, 23 FORBURY ROAD, READING, UNITED KINGDOM, RG1 3JH | 03022416 | 2017-12-31 | 1,123,545,000 | 198,818,000 | |
AMGEN LIMITED | 216 CAMBRIDGE SCIENCE PARK, MILTON ROAD, CAMBRIDGE, CAMBRIDGESHIRE, ENGLAND, CB4 0WA | 02354269 | 2017-12-31 | 238,931,000 | 9,488,000 | |
GENOME RESEARCH LIMITED | WELLCOME SANGER INSTITUTE WELLCOME GENOME CAMPUS, HINXTON, SAFFRON WALDEN, ENGLAND, CB10 1SA | 02742969 | 2018-09-30 | 144,812,000 | 55,555,000 | |
COVANCE LABORATORIES LIMITED | OTLEY RD, HARROGATE, HG3 1PY | 01171833 | 2017-12-31 | 111,519,000 | 16,839,000 | |
ASTEX THERAPEUTICS LIMITED | 436 CAMBRIDGE SCIENCE PARK, MILTON ROAD, CAMBRIDGE, CB4 0QA | 03751674 | 2018-12-31 | 72,199,766 | 28,006,138 | |
CELLTECH R&D LIMITED | 208 BATH ROAD, SLOUGH, BERKSHIRE, SL1 3WE | 01472269 | 2017-12-31 | 55,407,000 | -5,338,000 | |
QUOTIENT SCIENCES LIMITED | TRENT HOUSE MERE WAY, RUDDINGTON FIELDS BUSINESS PARK, RUDDINGTON, NOTTINGHAM, NG11 6JS | 05221615 | 2018-03-31 | 43,379,000 | 7,170,000 | |
CENTRE FOR PROCESS INNOVATION LIMITED | WILTON CENTRE, WILTON, REDCAR, CLEVELAND, TS10 4RF | 05002194 | 2018-03-31 | 33,187,000 | 7,344,000 |
72190-Other research and experimental development on natural sciences and engineering 82990-Other business support service activities not elsewhere classified 85320-Technical and vocational secondary education |
EVOTEC (UK) LIMITED | 114 INNOVATION DRIVE, MILTON PARK, MILTON, ABINGDON, OXFORDSHIRE, OX14 4RZ | 02674265 | 2017-12-31 | 31,859,000 | 1,599,000 | |
ARC TRINOVA LIMITED | C/O QUOTIENT SCIENCES LIMITED TRENT HOUSE MERE WAY, RUDDINGTON FIELDS BUSINESS PARK, RUDDINGTON, NOTTINGHAM, ENGLAND, NG11 6JS | 09767194 | 2017-12-31 | 8,422,519 | 0 | |
CROWN BIOSCIENCE UK LIMITED | BUILDING 14 DODGEFORD LANE, OSGATHORPE, LOUGHBOROUGH, LEICESTERSHIRE, LE12 9TE | 07109059 | 2017-12-31 | 2,819,775 | 0 | |
INDUSTRIAL MICROBIOLOGICAL SERVICES LIMITED | ODD FELLOWS HALL, 118B OXFORD ROAD, READING, RG1 7NG | 03264423 | 2018-01-31 | 1,005,784 | 0 | |
THE BIO NANO CENTRE UNLIMITED | 69 ONSLOW ROAD, ONSLOW ROAD, RICHMOND, ENGLAND, TW10 6QA | 06389520 | 2018-02-28 | 974,607 | 0 | |
TAILORED CLINICAL RESEARCH SOLUTIONS LIMITED | 2 HINKSEY COURT, CHURCH WAY, OXFORD, ENGLAND, OX2 9SX | 09930195 | 2017-12-31 | 334,157 | 0 |
86900-Other human health activities |
NEXT CLINICAL RESEARCH ORGANISATION LIMITED | 47 THE RIDGEWAY, FRIERN BARNET, LONDON, ENGLAND, N11 3LG | 09418105 | 2018-12-31 | 282,733 | 0 | |
MEDEZRIN LTD. | 71-75 SHELTON STREET, COVENT GARDEN, LONDON, UNITED KINGDOM, WC2H 9JQ | 03340737 | 2018-03-31 | 170,000 | 0 | |
NEW DIAGNOSTICS LIMITED | KNOLE VIEW, SOUTH HILL, SOMERTON, SOMERSET, TA11 7JQ | 08672341 | 2019-03-31 | 104,307 | 0 |
74909-Other professional, scientific and technical activities not elsewhere classified |
CLINICAL PHASE DEVELOPMENT LTD | 38 CABERFEIGH CLOSE, REDHILL, ENGLAND, RH1 6BF | 07715640 | 2018-07-31 | 94,690 | 0 | |
SEE-THROUGH SCIENTIFIC LIMITED | HARWOOD HOUSE, 43 HARWOOD ROAD, LONDON, ENGLAND, SW6 4QP | 09410281 | 2017-12-31 | 76,514 | 0 | |
DIAGNODUS LTD | ST JOHN'S INNOVATION CENTRE, COWLEY ROAD, CAMBRIDGE, ENGLAND, CB4 0WS | 07600875 | 2019-04-30 | 63,322 | 0 | |
FISHER STATISTICS CONSULTANCY LIMITED | 10 10 HEDGHOG CRESCENT, EDINBURGH, EH17 8XP, UNITED KINGDOM, EH17 8XP | SC385170 | 2018-09-30 | 54,959 | 0 |
72200-Research and experimental development on social sciences and humanities 85600-Educational support services |
SERNAT LIMITED | 173 BROADWAY, DIDCOT, ENGLAND, OX11 8RZ | 10372226 | 2017-09-30 | 51,815 | 0 |
72200-Research and experimental development on social sciences and humanities 86210-General medical practice activities |
COULSON BIOINFORMATICS LTD | EXCHANGE BUILDING, 66 CHURCH STREET, HARTLEPOOL, UNITED KINGDOM, TS24 7DN | 10904839 | 2018-08-31 | 48,628 | 0 | |
IHG PHARMACO LIMITED | 20-22 WENLOCK ROAD, LONDON, N1 7GU | 05606880 | 2018-03-31 | 43,960 | 0 | |
CALA PHARMA LIMITED | 5 FARRIERS WAY, WINSFORD, ENGLAND, CW7 2TS | 09883439 | 2017-11-30 | 35,084 | 0 | |
GOLGENE TECHNOLOGIES LIMITED | 24 CHELWOOD AVENUE, LEEDS, ENGLAND, LS8 2AZ | 06069931 | 2019-01-31 | 35,041 | 0 | |
GREENSTONE BIOLABS LTD | 024, WESTBOURNE STUDIOS, ACKLAM ROAD, LONDON, ENGLAND, W10 5JJ | 09874376 | 2017-11-30 | 33,043 | 0 |
72190-Other research and experimental development on natural sciences and engineering |
APPLIED EXOMICS LTD | LEE LARCOMBE, 39 HOGSDEN LEYS, ST. NEOTS, CAMBRIDGESHIRE, PE19 6AD | 08251827 | 2018-10-14 | 15,705 | 0 | |
SP SCIENTIFIC SERVICES LTD | 52 ANGEL HILL, SUTTON, UNITED KINGDOM, SM1 3EW | 10312528 | 2018-08-31 | 15,229 | 0 |
72190-Other research and experimental development on natural sciences and engineering |
CHEMOVATION LIMITED | WA10 1GH, 49 ARRIVATO PLAZA, HALL STREET, ST HELENS, UNITED KINGDOM, WA10 1GH | 05316858 | 2018-12-31 | 12,182 | 0 |
74909-Other professional, scientific and technical activities not elsewhere classified |
AXONICS MODULATION TECHNOLOGIES, U.K. LIMITED | 5TH FLOOR, ONE NEW CHANGE, LONDON, UNITED KINGDOM, EC4M 9AF | 09622653 | 2019-06-30 | 8,610 | 0 | |
RIOTECH PHARMACEUTICALS LIMITED | 49 ARRIVATO PLAZA,, HALL STREET, ST HELENS, UNITED KINGDOM, WA10 1GH | 04316377 | 2018-11-30 | 8,428 | 0 | |
GENOMEX LTD | BEECHCROFT DIKELANDS LANE, UPPER POPPLETON, YORK, UNITED KINGDOM, YO26 6JA | 10356872 | 2018-09-30 | 7,923 | 0 |
72190-Other research and experimental development on natural sciences and engineering |
ALLERAYDE SAB LIMITED | 1 MEADOW ROAD, NEWARK, NG24 3BP | 07909304 | 2019-01-31 | 4,348 | 0 | |
BIOMEMS TECHNOLOGIES LIMITED | 272 THE HAWTHORNS, CARDIFF, WALES, CF23 7AN | 09360659 | 2018-12-31 | 3,000 | 0 | |
OXFORD MEDISTRESS LTD | FLAT 1, 69, ONSLOW ROAD, RICHMOND, SURREY, ENGLAND, TW10 6QA | 05470178 | 2017-06-30 | 2,589 | 0 |
86900-Other human health activities |
ALCHEMY PHARMATECH LIMITED | KIRKSTONE GRINDLETON ROAD, WEST BRADFORD, CLITHEROE, LANCASHIRE, BB7 4TB | 07912825 | 2017-03-31 | 1,981 | 0 | |
PHYTOFUTURES LTD | 54 DAWLISH ROAD, LONDON, ENGLAND, E10 6QD | 09412092 | 2019-01-31 | 637 | 0 |
74909-Other professional, scientific and technical activities not elsewhere classified |
ALBANY CLINICAL CONSULTING LIMITED | 7 NEW BROUGHTON, EDINBURGH, MIDLOTHIAN, UNITED KINGDOM, EH3 6PA | SC532187 | 2018-04-30 | 295 | 0 | |
DYAX LTD | 1 KINGDOM STREET, LONDON, ENGLAND, W2 6BD | 08965623 | 2017-12-31 | 0 | 0 |
99999-Dormant Company |
ACUBLATE LIMITED | ANGEL BUILDING, 407 ST. JOHN STREET, LONDON, EC1V 4AD | 07209117 | 2018-03-31 | 0 | 0 | |
ARWAIN YMLAEN LIMITED | 32 CEDAR AVENUE, HAZLEMERE, HIGH WYCOMBE, HP15 7DW | 06062248 | 2019-03-31 | 0 | 0 | |
CELL RESEARCH TECHNOLOGY LTD | 32 FRIENDSHIP ROAD, BRISTOL, BS4 2RN | 08192207 | 2018-08-31 | 0 | 0 | |
DE NOVO PHARMACEUTICALS LIMITED | MAYPOLE COTTAGE LOWER GREEN, WIMBISH, SAFFRON WALDEN, ENGLAND, CB10 2XH | 03761178 | 2018-09-30 | 0 | 0 | |
FERTILITY INNOVATIONS LIMITED | COOMBE HOUSE, BRADFORD PEVERELL, DORCHESTER, DORSET, DT2 9SE | 07416896 | 2018-12-31 | 0 | 0 | |
GARSINGTON TECHNOLOGIES LIMITED | 4, THE GABLES, VALE OF HEALTH, HAMPSTEAD, LONDON, ENGLAND, NW3 1AY | 08782927 | 2018-11-30 | 0 | 0 | |
IOTA PHARMACEUTICALS LIMITED | ST JOHNS INNOVATION CENTRE, COWLEY ROAD, CAMBRIDGE, CAMBRIDGESHIRE, CB4 0WS | 06279987 | 2018-06-30 | 0 | 0 | |
LIF NANO RX LTD | APARTMENT 16 SPRINGS COURT, FIELD CLOSE, COTTINGHAM, ENGLAND, HU16 5GX | 08551193 | 2018-05-31 | 0 | 0 | |
MARBLEAMBER LIMITED | 29 GLADSTONE STREET, HATHERN, LOUGHBOROUGH, LEICESTERSHIRE, LE12 5LE | 07121238 | 2019-03-31 | 0 | 0 | |
NANO-NOSE LIMITED | 41 OAKWOOD PARK ROAD, LONDON, ENGLAND, N14 6QD | 11014188 | 2018-07-31 | 0 | 0 | |
PT VENTURES LIMITED | 1A TOWER ROAD, DARTFORD, ENGLAND, DA1 2HE | 09821026 | 2018-10-31 | 0 | 0 | |
W C LEE LIMITED | 94 HOWARD AVENUE, SLOUGH, BERKSHIRE, ENGLAND, SL2 1LA | 09508311 | 2018-03-31 | 0 | 0 | |
WALTERSTEAD LIMITED | ACADEMY HOUSE, SHEDDEN PARK ROAD, KELSO, ROXBURGHSHIRE, TD5 7AL | SC368318 | 2018-03-31 | 0 | 0 |
75000-Veterinary activities 82990-Other business support service activities not elsewhere classified |
RESPIRATORY CLINICAL TRIALS LIMITED | 1 TOWER HOUSE, TOWER CENTRE, HODDESDON, HERTFORDSHIRE, ENGLAND, EN11 8UR | 04063160 | 0000-00-00 | 0 | 0 |
LIQUIDATION RISK (BETA)
This company is Active. Statistically, Active companies have a low probability of being liquidated within a year.
Here are our probability predictions:
Basis | Liquidation within 3 months | Liquidation within 6 months | Liquidation within 12 months | Prediction confidence |
---|---|---|---|---|
REDX PHARMA PLC | 1.5% | 2.3% | 3.9% | Medium |
Other companies Active in the same sector | 1.2% | 3.5% | 7.4% | Medium |
Expanded sample | 1.3% | 2.3% | 3.9% | Medium |
Age | 0.4% | 1.7% | 3.3% | Medium |
Company Type | 1.7% | 4.0% | 5.9% | Medium |
Accounts category | 0.6% | 1.5% | 2.5% | Medium |
Accounting Month | 0.7% | 4.4% | 10.6% | Medium |
Sic code count | 0.7% | 3.5% | 7.0% | Medium |
VALUATION (BETA)
Valuation ratios as at 2024-02-28
Market Cap GBP | Enterprise Value GBP | PE | EV/Revenue | EV/EBITDA | |
---|---|---|---|---|---|
REDX PHARMA PLC | 71,960,000 | 119,868,000 | 21.1 | -14.6 | |
Pharmaceuticals Biotechnology and Marijuana Production ( 50 companies) |
234,298,520,000 | 270,471,569,110 | 24.6 (median) |
3.6 (median) |
8.6 (median) |